BEACON TRANSCRIPT – After thorough research, Medtronic developed a device that is meant to ease the life of patients suffering from both types of diabetes. This comes after reports that show how the number of both diabetes and obesity cases in the United States keeps rising.
The Centers for Disease Control and Prevention (CDC) revealed that around 9 percent of Americans suffer from diabetes. The rates are worryingly rising in Tennessee, where the number raised to 15 percent during the last decade. Also, obesity rates in Tennessee are above average.
The most widespread type of diabetes is Type 2 which, if it is not treated, it can cause further complications and eye, kidney, or heart problems. The lack of treatment can also lead to death. Since the body cannot produce the necessary amounts of insulin, people need an artificial source of the hormone.
Type 2 diabetes can be fought more easily if it is discovered in an early stage. Patients can combat the disease with a little more exercising, trying to maintain a normal weight and making drastic changes in their diet.
Type 1 diabetes is a more complicated form of the disease when the body stops producing insulin or it becomes resistant to it. Therefore, people suffering from this type of diabetes cannot keep it under control just with diet and exercise.
The standard treatment for Type 1 diabetes is the insulin injection before every meal and at bedtime. This process is quite painful and complicated, since the patients need to know their blood sugar levels to establish what quantity of insulin they must inject.
Thus, Medtronic are trying to make it a little easier for these people to administer their treatment. They are releasing the medical device MiniMed 670G this year in March. The device consists of a glucose monitor that registers the blood sugar levels and an insulin pump that provides the patients with the suitable amount they need to get injected.
Due to the technological advances, the monitor is now accurate enough, easy to use, and can help the patients take their treatment themselves, by calculating and offering exactly how much insulin they need. Thus, they no longer need medical assistance for their treatments.